Washington D.c., DC3 Active Studies

Neuroendocrine Tumors Clinical Trials in Washington D.c., DC

Find 3 actively recruiting neuroendocrine tumors clinical trials in Washington D.c., DC. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
458
Enrolling

Recruiting Neuroendocrine Tumors Studies in Washington D.c.

About Neuroendocrine Tumors Clinical Trials in Washington D.c.

Neuroendocrine tumors (NETs) develop from hormone-producing cells and can occur in many organs, most commonly the gastrointestinal tract and lungs. They range from slow-growing to aggressive. Treatment includes surgery, somatostatin analogs, targeted therapy, and peptide receptor radionuclide therapy.

There are currently 3 neuroendocrine tumors clinical trials recruiting participants in Washington D.c., DC. These studies are seeking a combined 458 participants. Research is being sponsored by RayzeBio, Inc., West-Ward Pharmaceutical, National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Neuroendocrine Tumors Clinical Trials in Washington D.c. — FAQ

Are there neuroendocrine tumors clinical trials in Washington D.c.?

Yes, there are 3 neuroendocrine tumors clinical trials currently recruiting in Washington D.c., DC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Washington D.c.?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Washington D.c. research site will contact you about next steps.

Are clinical trials in Washington D.c. free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Washington D.c. studies also compensate for your time and travel.

What neuroendocrine tumors treatments are being tested?

The 3 active trials in Washington D.c. are testing new therapies including novel drugs, biologics, and treatment approaches for neuroendocrine tumors.

Data updated March 2, 2026 from ClinicalTrials.gov